Press release
Deadline on Sept. 26th coming up in Lawsuit for certain investors in shares of Syneos Health, Inc. (NASDAQ: SYNH)
A Deadline is coming up on September 25, 2023 in the lawsuit for certain investors in Syneos Health, Inc. (NASDAQ: SYNH).
Investors who purchased shares of Syneos Health, Inc. (NASDAQ: SYNH) have certain options and there are strict and short deadlines running. Deadline: September 25, 2023. NASDAQ: SYNH stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of Syneos Health, Inc. (NASDAQ: SYNH) common shares between September 9, 2020 and November 3, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between September 9, 2020 and November 3, 2022, the defendants made false and/or misleading statements and/or failed to disclose that Syneos' business development capabilities had been materially impaired by workforce reductions and leadership and operational changes, as well as labor force turmoil caused by the COVID-19 pandemic, that Syneos had struggled to integrate recent acquisitions, causing Syneos to suffer from a bloated and confused organizational structure and impairing Syneos' ability to provide comprehensive or effective customer engagement across its product portfolio, that Syneos was suffering from acute competitive disadvantages as clinical trials moved to remote monitoring and decentralized administration, as Syneos lacked the tools possessed by some of its rivals to successfully run remote and decentralized trials, such as certain data visualization and statistical modeling capabilities, and Syneos had failed to adapt to changing business demands in the wake of the COVID-19 pandemic, that Syneos' backlog, book-to-bill ratios, and net new business awards had been artificially inflated by more than $500 million through the inclusion of reimbursable expenses that Syneos would never collect, that as a result of the above, Syneos was struggling to execute on its existing contracts and to agilely respond to its client needs, causing Syneos to suffer client dissatisfaction across its client base, and that consequently, Syneos was exposed to a material undisclosed risk that Syneos would lose customers, be unable to grow its client base or win significant contract renewals, and cede market share to its rivals.
Those who purchased shares of Syneos Health, Inc. (NASDAQ: SYNH) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on Sept. 26th coming up in Lawsuit for certain investors in shares of Syneos Health, Inc. (NASDAQ: SYNH) here
News-ID: 3207447 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Syneos
Nursing Staffing Solutions Market 2023 Business Tactics | TeamHealth, Syneos Hea …
This comprehensive Report of the Nursing Staffing Solutions Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. It represents a comprehensive and succinct analysis report of the main competitor and price statistics with a view to helping beginners establish their place and…
Oncology Clinical Trials Market Next Big Thing | Major Giants- IQVIA, PAREXEL, S …
Advance Market Analytics published a new research publication on "Oncology Clinical Trials Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Oncology Clinical Trials market was mainly driven by the increasing R&D spending across the world.
Major Players Profiled in the…
Bioanalytical Services Market To Witness Excellent Growth | IQVIA, Syneos Health …
HTF Market Intelligence published a new research document of 150+pages on" Bioanalytical Services Market Insights, to 2028" with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Bioanalytical Services market was mainly driven by the increasing R&D spending by leading and emerging player, however latest scenario and economic slowdown have…
Clinical CRO Market Trends and Growth During 2021-2027 | IQVIA, Covance, Syneos …
A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis.
The Growing demand for clinical trials in emerging countries along with increasing prevalence of chronic diseases is accelerating the market growth. Additionally, the market is driven by an increasing number of biologics and the demand for CROs to conduct clinical trials.…
Cervical Dystonia Pipeline 2020-2022| Revance Therapeutics, Inc., Syneos Health, …
The Global Cervical Dystonia Pipeline Insights 2020-2022: The research study has been prepared with the use of in-depth qualitative and quantitative analyses of the global Cervical Dystonia Market. The report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the Global Cervical Dystonia Market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, Manufacturing cost, prices, and other key factors related to the…
Bioanalytical Services Market SWOT Analysis by Key Players- ICON, Algorithme, PR …
A new business intelligence report released by HTF MI with title "Global Bioanalytical Services Market Size, Status and Forecast 2019-2025" is designed covering micro level of analysis by manufacturers and key business segments. The Global Bioanalytical Services Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and…
